Stay updated with breaking news from About Vafidemstat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
22 April 2024 ORYZON secures another important patent for its lead CNS asset, vafidemstat Has received Intention to Grant from the European...
3 October 2023 ORYZON receives two grants to further explore the role of epigenetic targets in the treatment of neuronal pathologies Two...
5 July 2023 Positive aggregate safety data from vafidemstat's ongoing Phase IIb PORTICO trial in Borderline Personality Disorder ...